Evidence map›Paper›PMID 27481845›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2016

Induction of Th1-Biased T Follicular Helper (Tfh) Cells in Lymphoid Tissues during Chronic Simian Immunodeficiency Virus Infection Defines Functionally Distinct Germinal Center Tfh Cells.

Vijayakumar Velu, Geetha Hanna Mylvaganam, Sailaja Gangadhara, Jung Joo Hong, Smita S Iyer, Sanjeev Gumber, Chris C Ibegbu, Francois Villinger, Rama Rao Amara

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 104 citations in OpenAlex.

  1. Trial
  2. Trial
  3. HIV reservoirs in lymphomagenesis: hidden driver in the era of viral suppression?Microbiology and molecular biology reviews : MMBR · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Activation of CXCR3Journal of virology · 2025
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. PD-1 blockade following ART interruption enhances control of pathogenic SIV in rhesus macaques.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Vijayakumar VeluEmory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329;ORCID 0000-0003-4238-1924
Geetha Hanna MylvaganamEmory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329;
Sailaja GangadharaEmory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329;ORCID 0000-0001-8603-628X
Jung Joo HongEmory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329; National Primate Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang, Korea 363-883;ORCID 0000-0002-9795-6513
Smita S IyerEmory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329;
Sanjeev GumberDepartment of Pathology, Emory University School of Medicine, Atlanta, GA 30322;ORCID 0000-0001-9048-2717
Chris C IbegbuEmory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322; and.
Francois VillingerEmory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329; Department of Pathology, Emory University School of Medicine, Atlanta, GA 30322; New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA 70560.
Rama Rao AmaraEmory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322; and ramara@emory.edu.ORCID 0000-0002-6309-6797
Emory University · US

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
YNPRC NHP CLINICAL MEDICINE RESIDENCY PROGRAM - SUPPLEMENTP51RR000165 · NCRR · EMORY UNIVERSITY · PI ALTMAN, JOHN DAVID · 1985 to 2011
$114.0M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Carlos del Rio · 2002 to 2026
$74.0M
Nonhuman Primate Reagent ResourceU24AI126683 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Diogo Magnani · 2016 to 2026
$20.1M
Targeting mTOR to Enhance Immunogenicity and Efficacy of HIV VaccinesP01AI088575 · NIAID · EMORY UNIVERSITY · PI AMARA, RAMA RAO · 2010 to 2013
$11.4M
Preclinical Studies and T cell ResponsesU19AI109633 · NIAID · EMORY UNIVERSITY · PI VELU, VIJAYAKUMAR · 2014 to 2018
$10.2M
Targeting PD-1 Pathway for Functional Cure of AIDSR37AI112787 · NIAID · EMORY UNIVERSITY · PI AMARA, RAMA RAO · 2014 to 2023
$9.2M
Resource for Nonhuman Primate Immune ReagentsR24OD010947 · OD · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI VILLINGER, FRANCOIS J · 2012 to 2025
$4.9M
Therapeutic DNA/MVA Vaccines for HIVR01AI071852 · NIAID · EMORY UNIVERSITY · PI AMARA, RAMA RAO · 2007 to 2009
$2.9M
PD-1 blockade combined with vaccination as a therapy for SIV/AIDSRC2CA149086 · NCI · EMORY UNIVERSITY · PI AMARA, RAMA RAO · 2009 to 2010
$999k
CYTOMETRIC CD4 COUNTING - A MINIMALIST APPROACHR43AI074471 · NIAID · HOWARD M. SHAPIRO, MD, P.C. · PI SHAPIRO, HOWARD M. · 2007 to 2007
$98k
NCI NIH HHS RC2 CA149086NCRR NIH HHS P51 RR000165NIAID NIH HHS P01 AI088575NIAID NIH HHS P30 AI050409NIAID NIH HHS R01 AI071852NIAID NIH HHS R37 AI112787NIAID NIH HHS R43 AI074471NIAID NIH HHS U19 AI109633NIAID NIH HHS U24 AI126683NIH HHS P51 OD011132NIH HHS R24 OD010947
6 · The paper itself

Abstract

Chronic HIV infection is associated with accumulation of germinal center (GC) T follicular helper (Tfh) cells in the lymphoid tissue. The GC Tfh cells can be heterogeneous based on the expression of chemokine receptors associated with T helper lineages, such as CXCR3 (Th1), CCR4 (Th2), and CCR6 (Th17). However, the heterogeneous nature of GC Tfh cells in the lymphoid tissue and its association with viral persistence and Ab production during chronic SIV/HIV infection are not known. To address this, we characterized the expression of CXCR3, CCR4, and CCR6 on GC Tfh cells in lymph nodes following SIVmac251 infection in rhesus macaques. In SIV-naive rhesus macaques, only a small fraction of GC Tfh cells expressed CXCR3, CCR4, and CCR6. However, during chronic SIV infection, the majority of GC Tfh cells expressed CXCR3, whereas the proportion of CCR4(+) cells did not change, and CCR6(+) cells decreased. CXCR3(+), but not CXCR3(-), GC Tfh cells produced IFN-γ (Th1 cytokine) and IL-21 (Tfh cytokine), whereas both subsets expressed CD40L following stimulation. Immunohistochemistry analysis demonstrated an accumulation of CD4(+)IFN-γ(+) T cells within the hyperplastic follicles during chronic SIV infection. CXCR3(+) GC Tfh cells also expressed higher levels of ICOS, CCR5, and α4β7 and contained more copies of SIV DNA compared with CXCR3(-) GC Tfh cells. However, CXCR3(+) and CXCR3(-) GC Tfh cells delivered help to B cells in vitro for production of IgG. These data demonstrate that chronic SIV infection promotes expansion of Th1-biased GC Tfh cells, which are phenotypically and functionally distinct from conventional GC Tfh cells and contribute to hypergammaglobulinemia and viral reservoirs.

Indexed as

AnimalsB-LymphocytesCD40 LigandFemaleGerminal CenterHypergammaglobulinemiaImmunoglobulin GInterferon-gammaInterleukin-21InterleukinsLymphoid TissueMacaca mulattaReceptors, CCR4Receptors, CCR6Receptors, CXCR3Receptors, CXCR5CD40 LigandImmunoglobulin GInterferon-gammaInterleukin-21InterleukinsReceptors, CCR4Receptors, CCR6Receptors, CXCR3Receptors, CXCR5

Identifiers

PMID27481845
PMCPMC4992610
OpenAlexW2486196806

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.